gefitinib has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Shlomo, A; Cooper, O | 1 |
| Donangelo, I; Gutman, S; Melmed, S; Ren, SG; Siegel, E; Vlotides, G | 1 |
| Bannykh, S; Cooper, O; Fukuoka, H; Melmed, S; Mizutani, J; Ren, SG; Tong, Y | 1 |
1 review(s) available for gefitinib and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Role of tyrosine kinase inhibitors in the treatment of pituitary tumours: from bench to bedside.
Topics: Animals; Cell Line, Tumor; ErbB Receptors; Gefitinib; Humans; Lapatinib; Mice; Mice, Transgenic; Pituitary Neoplasms; Prolactinoma; Protein Kinase Inhibitors; Quinazolines; Translational Research, Biomedical | 2017 |
2 other study(ies) available for gefitinib and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands.
Topics: Animals; Antineoplastic Agents; Base Sequence; Blotting, Western; Cell Division; Cell Line, Tumor; Cell Proliferation; DNA Primers; ErbB Receptors; Female; Flow Cytometry; Gefitinib; Gene Expression; Immunoprecipitation; Ligands; Mice; Mice, Nude; Pituitary Neoplasms; Polymerase Chain Reaction; Prolactinoma; Quinazolines; Rats | 2008 |
HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: strategy for targeted prolactinoma therapy.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Lactotrophs; Lapatinib; Molecular Targeted Therapy; Prolactin; Prolactinoma; Quinazolines; Rats; Receptor, ErbB-2; RNA, Messenger; Signal Transduction | 2011 |